This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Feb;83(2):264-5.

doi: 10.1016/j.urology.2013.10.031. Epub 2013 Dec 12.

Editorial comment

Robert Dreicer¹

Affiliations

PMID: 24332124
DOI: 10.1016/j.urology.2013.10.031

Editorial

Editorial comment

Robert Dreicer. Urology. 2014 Feb.

. 2014 Feb;83(2):264-5.

doi: 10.1016/j.urology.2013.10.031. Epub 2013 Dec 12.

Author

Robert Dreicer¹

Affiliation

¹ Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.

PMID: 24332124
DOI: 10.1016/j.urology.2013.10.031

No abstract available

PubMed Disclaimer

Comment on

Clinical trial design for the development of new therapies for nonmuscle-invasive bladder cancer: report of a Food and Drug Administration and American Urological Association public workshop.
Jarow JP, Lerner SP, Kluetz PG, Liu K, Sridhara R, Bajorin D, Chang S, Dinney CP, Groshen S, Morton RA, O'Donnell M, Quale DZ, Schoenberg M, Seigne J, Vikram B. Jarow JP, et al. Urology. 2014 Feb;83(2):262-4. doi: 10.1016/j.urology.2013.10.030. Epub 2013 Dec 12. Urology. 2014. PMID: 24332121

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information